ELA026

· Electra Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ELA026, covering 2026-03-12 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH) [Phase 2, Phase 3]

See pricing